Home/ Supplements/ Electrolytes/ OsteoVantiv

OsteoVantiv

product on market Tablet or Pill Metagenics Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 33% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Magnesium and standardized cartilage are supported by moderate evidence for maintaining bone and joint health. Research on tetrahydro-iso-alpha acids is more limited, though they are studied for their potential anti-inflammatory effects. Together, these ingredients target musculoskeletal support with a high safety profile.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for OsteoVantiv
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Tablet(s)
Serving Size
60
Servings
Other Combinations
Product Type
33%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

37.5 mg (9% DV)
Within RDA (0.1× RDA) 316 studies (A:8, B:159)
standardized Cartilage
20 mg
Tetrahydro-Iso-Alpha Acids
300 mg

Other Ingredients

Microcrystalline Cellulose Maltodextrin Calcium Silicate Croscarmellose Sodium Stearic Acid Cellulose Silica Potassium Chloride Coating
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions: Take one tablet twice daily with food or as directed by your healthcare practitioner.

Warnings & Precautions

Caution: Do not use if pregnant or nursing. If taking other nutritional supplements or medications, consult your healthcare practitioner before use.

Keep out of the reach of children.

Formulation Notes

OsteoVantiv is designed to comfort sore joints and promote joint flexibility in healthy people following exercise. It features a clinically effective dose of UC-II, containing undenatured type II collagen, which has been shown in research to support joint health. OsteoVantiv also features a proprietary, enriched form of THIA - -a breakthrough ingredient for enhanced joint relief.

This product is non-GMO and gluten-free.

Provides joint relief & supports joint flexibility

Additional Information

Storage: Keep tightly closed in a cool, dry place.

Certified gluten-free

Practitioner exclusive

Metadata

Product Details

DSLD Entry Date2019-12-22
Product TypeOther Combinations
FormTablet or Pill
DSLD ID209681
Data Updated2026-04-11
Research

Research Evidence

849
Research Sources
56
Avg Quality
450
Meta Analysis
152
Rct
137
Systematic Review
73
Clinical Trial
11
Regulatory Source
7
Other
7
Guideline
3
Openfda Safety
2
Cochrane Review
2
Observational
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
A Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps
Systematic Review The Cochrane database of systematic reviews 2008 PubMed DOI
A Calcium and vitamin D for increasing bone mineral density in premenopausal women
Systematic Review The Cochrane database of systematic reviews 2023 PubMed DOI
A Dietary sodium, sodium-to-potassium ratio, and risk of stroke: A systematic review and nonlinear dose-response meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2019 PubMed DOI
A The association between circulating magnesium and clinically relevant outcomes in patients with chronic kidney disease: A systematic review and meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2021 PubMed DOI
A Calcium channel blockers versus other classes of drugs for hypertension
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
View all evidence for Electrolytes →
Compare

Similar Products

View all Electrolytes products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.